Alexander Waddell

Alexander Waddell

Auto-generated profile, based on publicly available information

Alexander Waddell

School of Sport, Exercise & Rehabilitation Sciences University of Birmingham Birmingham UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Vascular Medicine
Verified
Journal Article
Open access
PDF file
AWAlexander Waddell
Alexander Waddell
SSSally Seed
Sally Seed
DBDavid R Broom
David R Broom
GMGordon McGregor
Gordon McGregor
SBStefan T. Birkett
Stefan T. Birkett
AHAmy E. Harwood
Amy E. Harwood
Intermittent claudication (IC) is a classic symptom of peripheral artery disease, with first line treatment being supervised exercise therapy (SET). Despite this, SET is frequently underutilised, and adherence is often poor. An alternative option are home-based exercise programmes (HBEP). Although HBEPs are well tolerated, to the authors’ knowledge, no research has assessed their safety. The aim of this review was to assess the safety of HBEPs in people living with IC. We performed an electronic search of the MEDLINE, CINAHL, and Cochrane Library databases. The main parameter of interest was complication rate, calculated as the number of related adverse events per patient-hours. Subanalysis was undertaken to determine differences in safety for studies that did and did not include pre-exercise cardiac screening, and for studies with exercise at low, moderate, and high levels of claudication pain. Our search strategy identified 8693 results, of which 27 studies were included for full review. Studies included 1642 participants completing 147,810 patient-hours of home-based exercise. Four related adverse events were reported, three of which were cardiac in origin, giving an all-cause complication rate of one event per 36,953 patient-hours. Three of these events occurred following exercise to high levels of claudication pain, and one occurred with pain-free exercise. One event occured in a study without cardiac screening. Based on the low number of related adverse events, HBEPs appear to be a safe method of exercise prescription for people with IC. Our results strengthen the rationale for providing alternative exercise options for this population. PROSPERO Registration No.: CRD42021254581

25 January 2024 in Journal of Science and Medicine in Sport
Verified
Journal Article
Open access
AWAlexander Waddell
Alexander Waddell
SBStefan Birkett
Stefan Birkett
DBDavid Broom
David Broom
GMGordon McGregor
Gordon McGregor
AHAmy E. Harwood
Amy E. Harwood
Commercially available wearable activity monitors can promote physical activity behaviour. Clinical trials typically quantify physical activity with research grade activity monitors prior to testing interventions utilising commercially available wearable activity monitors aimed at increasing step count. Therefore, it is important to test the agreement of these two types of activity monitors. Observational. Thirty adults (20-65 years, n = 19 females) were provided a Fitbit Charge 4©. To determine reliability using an intraclass correlation coefficient, two, one-minute bouts of treadmill walking were performed at a self-selected pace. Subsequently, participants wore both an ActiGraph wGT3X-BT and the Fitbit for seven days. To determine agreement, statistical equivalence and the mean absolute percentage error were calculated and represented graphically with a Bland-Altman plot. Ordinary least products regression was performed to identify fixed or proportional bias. The Fitbit showed 'good' step count reliability on the treadmill (intraclass correlation coefficient = 0.75, 95 % CI = 0.53-0.87, p < 0.001). In free-living however, it overestimated step count when compared to the ActiGraph wGT3X-BT (mean absolute percentage error = 26.02 % ± 14.63). Measurements did not fall within the ± 10 % equivalence region and proportional bias was apparent (slope 95 % CI = 1.09-1.35). The Fitbit Charge 4© is reliable when measuring step count on a treadmill. However, there is an overestimation of daily steps in free-living environments which may falsely indicate compliance with physical activity recommendations.

4 April 2024 in Annals of Vascular Surgery
Verified
Journal Article
Open access
AWAlexander Waddell
Alexander Waddell
FDFrancesca Denton
Francesca Denton
RPRichard Powell
Richard Powell
DBDavid R. Broom
David R. Broom
SBStefan T. Birkett
Stefan T. Birkett
AHAmy E. Harwood
Amy E. Harwood
Supervised exercise training is recommended for people with peripheral artery disease (PAD), yet it remains underutilized. Home-based exercise programs (HBEPs) are a potential alternative. The aim of this study was to assess the feasibility of conducting a full scale trial of a 12-week HBEP for people living with symptomatic PAD. In a randomized feasibility trial, patients with intermittent claudication were allocated to either an HBEP or a nonexercise control. The HBEP group was given a Fitbit to use during a 12-week exercise program comprising of personalized step goals and a resistance-based circuit to be undertaken at home twice weekly. The primary outcome was feasibility, assessed via eligibility, recruitment, attrition, tolerability, and adherence. Acceptability was assessed via semistructured interviews. Secondary analysis was undertaken to determine the feasibility of collecting clinical outcome data. 188 people were screened, 133 were eligible (70.7%), 30 were recruited (22.6%) and one withdrew (3.33%). Mean adherence to the daily step goal was 53.5% (range = 29.8-90.5%), and 58.6% of prescribed circuits were completed of which 56.4% were at the desired intensity. Six adverse events were recorded, 3 of which were related to study involvement. No significant differences were observed in exploratory outcomes. Small clinically important differences were seen in walking speed and pain-free treadmill walking distance which should be confirmed or refuted in a larger trial. The HBEP was feasible and well tolerated, with successful recruitment and minimal attrition. The intervention was acceptable, with walking seen as more enjoyable than circuit exercise. The WALKSTRONG program may be suitable for those who will not, or cannot, take part in supervised exercise outside of the home.

24 August 2026 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
AWAlexander Waddell
Alexander Waddell
MKMarie Korzepa
Marie Korzepa
ABArchie E. Belfield
Archie E. Belfield
BFBen Fry
Ben Fry
Rickson C. MesquitaRickson C. Mesquita
Rickson C. Mesquita
LBLeigh Breen
Leigh Breen
Reductions in musculoskeletal mass and function can occur with ageing and disuse. While resistance exercise training is known to minimise these detriments, it is not always feasible. Vortex wave stimulation (VWS) may mitigate skeletal muscle decline in such scenarios. The aim of the present study was to explore the acute physiological and metabolic effects of VWS in healthy older adults. Fourteen participants consumed deuterium oxide (D 2 O) stable oral isotope tracer for 7 days. Serial skeletal muscle biopsies were obtained to measure integrated rates of myofibrillar (iMyoPS) and sarcoplasmic (iSarcPS) muscle protein synthesis and regulatory signalling over ∼48 h before (habitual) and after two consecutive‐day bouts of VWS. Myoelectrical activity and muscle oxygenation during VWS, and pre‐post changes in peripheral blood flow and concentrations of inflammatory and bone turnover markers were also measured. There was an increase in iMyoPS (0.23% day −1 , P = 0.025), but not iSarcPS (0.07% day −1 , P = 0.582) above habitual rates following VWS. There was no difference in the expression of anabolic signalling proteins, nor peripheral blood flow following VWS. Myoelectrical activity increased during VWS (9.47 µV, P = 0.010), while muscle oxygenation decreased at the gastrocnemius ( P = 0.001) and quadriceps ( P = 0.017). There was a reduction in P1NP (8.27 µg L −1 ) and lactate (0.84 mmol L −1 ) concentration post‐VWS (both P < 0.001), while there was no difference in other biomarkers. This is the first study to demonstrate that VWS elicits acute physiological responses congruent with musculoskeletal adaptive remodelling, which warrants further exploration. image Key points: Resistance exercise is known to mitigate skeletal muscle atrophy associated with ageing and/or disuse but is not always feasible. We investigated, for the first time, the effects of a novel mechanical stimulus – vortex wave stimulation (VWS) – on integrated rates of myofibrillar and sarcoplasmic muscle protein synthesis, alongside other musculoskeletal and physiological outcomes, in healthy older adults. We demonstrated that VWS elevated myofibrillar, but not sarcoplasmic muscle protein synthesis compared to baseline, while increasing myoelectrical activity and reducing muscle oxygen saturation, lactate and bone turnover markers. These findings suggest VWS elicits acute physiological responses congruent with musculoskeletal adaptive remodelling.

28 September 2024 in Journal of Vascular Nursing
Verified
Journal Article
Open access
AWAlexander Waddell
Alexander Waddell
FDFrancesca Denton
Francesca Denton
RPRichard Powell
Richard Powell
DBDavid R. Broom
David R. Broom
SBStefan T. Birkett
Stefan T. Birkett
AHAmy E. Harwood
Amy E. Harwood
Introduction: The WALKSTRONG trial includes a programme of community walking and home-based circuit training which has been developed for people with intermittent claudication (IC). The aim of the present study was to determine the acceptability of the programme for those who took part, by gleaning their opinions and experiences. Methods: All participants eligible for the WALKSTRONG trial were approached regarding completing a semi-structured interview, selected from three groups: A) programme completers, B) programme with- drawers and C) programme decliners. Interviewers were interested in participants' views on the programme structure, willingness to participate, and the experiences of those who did take part. Interviews were audio recorded, transcribed verbatim and thematic analysis was undertaken. Results: Five of the 14 participants in the intervention group and four of the 20 programme decliners agreed to an interview. The one who withdrew from the exercise programme did not consent to be interviewed. The three themes that emerged from the interviews were: 1) 'overall positive experiences with the programme, 2) 'importance of guidance and pain management', and 3) 'barriers are both similar to supervised exercise and unique to home-based programmes'. The programme was well received by programme completers, with some aspects preferred over others. Some participants reported improvements in both physical activity behaviour and IC symptoms, and would recommend the programme to others. Conclusion: The home-based circuit programme received several recommendations for further improvement. Along with the feasibility findings, a fully powered, randomised controlled trial of this intervention is warranted. Trial registration: NCT05059899. (c) 2024 The Authors. Published by Elsevier Inc. on behalf of Society for Vascular Nursing, Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

1 January 2026 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
EHEoin Haigney
Eoin Haigney
AWAlexander Waddell
Alexander Waddell
MKMarie Korzepa
Marie Korzepa
ABArchie E. Belfield
Archie E. Belfield
BLBjørn Liaset
Bjørn Liaset
LBLeigh Breen
Leigh Breen
Exercise-induced muscle damage (EIMD) impairs muscle function and subsequent performance. While research investigating the protective role of animal-derived protein is widespread, investigations into sustainable alternatives are lacking. The present study examined the effects of a novel, salmon-derived protein peptide (SPP) on muscle recovery. In a single-blind, parallel-design, 33 recreationally active adults (age: 23.9 ± 4.0 years, body mass index: 23.7 ± 4.0) were randomly assigned to one of three groups: (a) SPP, (b) whey protein, or (c) carbohydrate control. In addition to a controlled 1.0 g·kg body mass −1 ·day −1 dietary protein intake, participants consumed either 0.9 g·kg body mass −1 ·day −1 supplemental protein or isoenergetic carbohydrate for 4 days following EIMD (10 × 10 unilateral eccentric knee extensions). Maximal voluntary contraction, countermovement jump height, muscle soreness, thigh circumference, creatine kinase, and lactate dehydrogenase were assessed at baseline and +1, +4, +24, +48, and +72 hr post EIMD. Significant time effects were observed for all variables. Countermovement jump height was greater in the SPP versus carbohydrate groups at +72 hr and across all time points when pooling the two protein groups, creating a higher protein versus normal protein group comparison. There were no significant group effects for all remaining outcomes. High-quality protein supplementation >1.0 g·kg body mass −1 ·day −1 appears to have only a modest effect on the rate of recovery following EIMD, with a potential role in alleviating muscle damage, particularly in the later stage of recovery. Furthermore, the SPP supplement was not inferior to a high-quality protein source (whey protein), indicating that it may represent a sustainable and effective alternative for muscle recovery.